Unilever has signed an agreement to acquire the Fluocaril and Parogencyl oral care brands from The Procter & Gamble Company (P&G).
Fluocaril and Parogencyl are both therapeutics brands that are primarily found in France and Spain’s pharmacy sector. Fluocaril offers oral care solutions specialising in protection against cavities. Parogencyl tackles gum issues.
Unilever hopes that the acquisition, which is expected to close in the second quarter of 2019, will boost its position in oral care within the French pharmacy channel as well as improving its position in Spain.
The terms of the deal were not disclosed.